Two Roche Alzheimer’s Assays Win US FDA Breakthrough Device Status
Executive Summary
The company is getting its data ready for submission to FDA for the Elecsys cerebrospinal fluid assays and hopes the new Breakthrough Device designation will increase interaction with the agency and speed the path to approval.
You may also be interested in...
Alzheimer's Is A Repeat Target For FDA Breakthrough Device Path
NeuroDiagnostics LLC said its investigational Alzheimer's disease test had been designated by US FDA as a Breakthrough Device. This is at least the third company to achieve that recognition for technology targeting Alzheimer's this year.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.